首页> 外国专利> ABRIN-CONTAINING PREVENTIVE AND REMEDY FOR MYCOPLASMA PNEUMONIA

ABRIN-CONTAINING PREVENTIVE AND REMEDY FOR MYCOPLASMA PNEUMONIA

机译:肺炎性支原体肺炎的含预防性和补救措施

摘要

PURPOSE:A novel drug useful for preventing and remedying mycoplasma pneumonia, containing a killed mold of the genus Mycoplasma and abrin. CONSTITUTION:The titled preventive and remedy containing a killed mold of the genus Mycoplasma and abrin. Abrin is a lectin isolated from seed from Abrus precatorius, a leguminous plant growing naturally in the tropics and the subtropics and a glycoprotein having about 65,000 molecular weight. When a killed mold of the genus Mycoplasma and abrin are administed to a patient with mycoplasma pneumonia, it is found that a cellular immunity reaction is promoted depending upon a dose of abrin, and infection protection effect is increased and development of vaccine is expected. A dose of the killed mold of the genus Mycoplasma is usually 105-1010 per human or animal properly and the minimum amount is 3 ng per human or animal independently of weight.
机译:目的:一种用于预防和治疗支原体肺炎的新型药物,它含有被杀死的支原体和阿布林菌。组成:标题为预防和补救措施,其中含有被杀死的支原体和阿布林菌。阿布林是一种植物凝集素,其是从速生亚种(Abrus precatorius),在热带和亚热带自然生长的豆科植物和分子量约为65,000的糖蛋白的种子中分离出来的。发现对支原体肺炎患者施用支原体和阿布林属的被杀死的霉菌时,发现其依赖于阿布林的剂量促进细胞免疫反应,并且增加了感染保护作用,并有望开发疫苗。支原体属的被杀死的霉菌的剂量通常为每人或动物适当的10 5 -10 10个,最小量为每人或动物独立于体重的3 ng。

著录项

  • 公开/公告号JPS6267029A

    专利类型

  • 公开/公告日1987-03-26

    原文格式PDF

  • 申请/专利权人 EISAI CO LTD;

    申请/专利号JP19850205340

  • 发明设计人 YAMAMOTO HIROSHI;

    申请日1985-09-19

  • 分类号A61K39/00;A61K38/36;

  • 国家 JP

  • 入库时间 2022-08-22 07:23:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号